EA201992617A1 - Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения - Google Patents

Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения

Info

Publication number
EA201992617A1
EA201992617A1 EA201992617A EA201992617A EA201992617A1 EA 201992617 A1 EA201992617 A1 EA 201992617A1 EA 201992617 A EA201992617 A EA 201992617A EA 201992617 A EA201992617 A EA 201992617A EA 201992617 A1 EA201992617 A1 EA 201992617A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
radiation
reducing
exposure
modification
Prior art date
Application number
EA201992617A
Other languages
English (en)
Inventor
Джозеф Эдвард Шульц
Роджер Харт
Брент Велборн
Original Assignee
Амген Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амген Инк. filed Critical Амген Инк.
Publication of EA201992617A1 publication Critical patent/EA201992617A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/24—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Предложены способы инактивации вируса в образце, содержащем белковый компонент. Также предложены способы уменьшения разложения или модификации белка в присутствии реакционноспособных веществ, таких как реакционноспособные вещества, образующиеся в результате воздействия УФ-излучения. Согласно другому аспекту предложен способ уменьшения окисления остатков метионина, остатков триптофана либо и остатков метионина, и остатков триптофана в белке, подвергаемом воздействию УФ-излучения. Предложенные способы могут быть реализованы в любом масштабе и могут быть, если требуется, автоматизированы.
EA201992617A 2011-10-26 2012-10-25 Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения EA201992617A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161551822P 2011-10-26 2011-10-26

Publications (1)

Publication Number Publication Date
EA201992617A1 true EA201992617A1 (ru) 2020-03-10

Family

ID=47138200

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201490867A EA034347B1 (ru) 2011-10-26 2012-10-25 Способ инактивации вирусов при получении антител
EA201992617A EA201992617A1 (ru) 2011-10-26 2012-10-25 Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201490867A EA034347B1 (ru) 2011-10-26 2012-10-25 Способ инактивации вирусов при получении антител

Country Status (16)

Country Link
US (1) US10634589B2 (ru)
EP (1) EP2771038B1 (ru)
JP (2) JP6526414B2 (ru)
KR (1) KR102091294B1 (ru)
CN (1) CN104136047B (ru)
AU (1) AU2012328753A1 (ru)
BR (1) BR112014010027A2 (ru)
CA (1) CA2853371A1 (ru)
EA (2) EA034347B1 (ru)
ES (1) ES2693508T3 (ru)
HK (1) HK1203423A1 (ru)
IL (1) IL232019A0 (ru)
MX (1) MX361039B (ru)
SG (1) SG11201401739YA (ru)
WO (1) WO2013063298A1 (ru)
ZA (1) ZA201402923B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603956B2 (en) * 2013-12-12 2017-03-28 Paul Newham Dynamic enhanced and diffuse broad spectrum UVC or alternative controlled ionizing radiation source emitters for mobile and fixed placement disinfection of clinical surfaces
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
ES2909630T3 (es) 2014-06-04 2022-05-09 Amgen Inc Métodos de recolección en cultivos de células de mamífero
ES2784503T3 (es) 2014-12-01 2020-09-28 Amgen Inc Procedimiento para manipular el nivel de contenido de glicano de una glicoproteína
EP3534947A1 (en) 2016-11-03 2019-09-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
CN107496950B (zh) * 2017-08-18 2021-02-02 广州市众为生物技术有限公司 一种紫外线照射灭活蛋白溶液中病毒的方法
US20230256130A1 (en) 2020-07-27 2023-08-17 Riken Infection prevention device and infection prevention method
EP4189064A1 (en) 2020-07-30 2023-06-07 Amgen Inc. Cell culture media and methods of making and using the same

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981163A (en) * 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０
DE69434445T2 (de) 1993-05-28 2006-05-18 New York Blood Center, Inc. Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt
JPH0758031A (ja) * 1993-08-18 1995-03-03 Nissin Electric Co Ltd イオン蒸着薄膜形成装置及び該装置を用いた成膜方法
US5925885A (en) * 1996-05-22 1999-07-20 Purepulse Technologies, Inc. Parametric control in pulsed light sterilization of packages and their contents
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
JPH11286453A (ja) * 1998-03-31 1999-10-19 Yoshitomi Pharmaceut Ind Ltd 紫外線照射によるタンパク質含有組成物のウイルス不活化処理方法
GB9821342D0 (en) 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
NZ542400A (en) * 1999-10-08 2007-05-31 Britesmile Professional Inc Apparatus for simultaneous illumination of teeth
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
EP1299131A4 (en) 2000-03-23 2003-06-18 Clearant Inc METHOD FOR STERILIZING BIOLOGICAL MATERIALS
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US20030064001A1 (en) * 2001-05-17 2003-04-03 Fries William M. System for the decontamination of fluid products using light
JP2004533318A (ja) * 2001-05-17 2004-11-04 ピュアパルス テクノロジーズ インコーポレイテッド 光を使用して流体製品を処理するシステムに関する方法および装置
WO2002096471A2 (en) 2001-05-30 2002-12-05 Gambro, Inc. Viral inactivation process using antioxidant
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
GB0117571D0 (en) * 2001-07-19 2001-09-12 Common Services Agency UV irradiation control
US20030059338A1 (en) 2001-09-24 2003-03-27 Mann David M. Methods for sterilizing biological materials using flavonoid/flavonol stabilizers
US20030064000A1 (en) * 2001-09-24 2003-04-03 Wilson Burgess Methods of sterilizing biological mixtures using stabilizer mixtures
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
ES2545067T3 (es) * 2002-04-26 2015-09-08 Genentech, Inc. Purificación de proteínas basada en la no afinidad
EP1415669A1 (en) * 2002-09-19 2004-05-06 Aventis Behring GmbH Process for sterilization of protein containing biological compositions
SI1581649T1 (sl) 2002-12-20 2011-09-30 Amgen Inc Vezna sredstva, ki zavirajo miostatin
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
US20050264236A1 (en) * 2004-05-25 2005-12-01 Purepulse Technologies, Inc Apparatus and method for use in triggering a flash lamp
US7993580B2 (en) * 2004-08-24 2011-08-09 Baxter International Inc. Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors
CA2614329C (en) 2005-07-06 2013-01-29 Navigant Biotechnologies, Llc Methods for reducing pathogens in biological samples
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
CA2632519A1 (en) 2005-12-06 2007-07-05 Amgen Inc. Polishing steps used in multi-step protein purification processes
AU2008228823A1 (en) * 2007-03-22 2008-09-25 Imclone Llc Stable antibody formulations
JP5579599B2 (ja) * 2007-06-15 2014-08-27 アムジエン・インコーポレーテツド バイオリアクターにおいて使用する細胞培養培地の処理方法
CA2708585A1 (en) * 2007-12-10 2009-06-18 Novartis Ag Analysis of mixtures including proteins
US7585679B1 (en) * 2008-02-22 2009-09-08 Dionex Corporation Ion chromatography system with flow-delay eluent recycle
US9545438B2 (en) * 2008-02-29 2017-01-17 Universiteit Gent Determination of antigenicity of an inactivated virus
EP2268805B1 (en) * 2008-03-06 2015-05-06 Halozyme, Inc. Large-scale production of soluble hyaluronidase
MX2011002372A (es) * 2008-09-10 2011-04-04 Genentech Inc Composiciones y metodos para la prevencion de la degradacion oxidativa de proteinas.
JP5715126B2 (ja) * 2009-07-09 2015-05-07 コーニンクレッカ フィリップス エヌ ヴェ 皮膚照射装置

Also Published As

Publication number Publication date
CA2853371A1 (en) 2013-05-02
AU2012328753A1 (en) 2014-04-24
HK1203423A1 (en) 2015-10-30
MX2014004880A (es) 2014-09-15
SG11201401739YA (en) 2014-05-29
IL232019A0 (en) 2014-05-28
WO2013063298A1 (en) 2013-05-02
MX361039B (es) 2018-11-26
US20140329227A1 (en) 2014-11-06
EA034347B1 (ru) 2020-01-30
KR102091294B1 (ko) 2020-04-16
CN104136047A (zh) 2014-11-05
JP6526414B2 (ja) 2019-06-05
EP2771038B1 (en) 2018-10-10
JP2017061462A (ja) 2017-03-30
JP2014533942A (ja) 2014-12-18
ZA201402923B (en) 2015-04-29
ES2693508T3 (es) 2018-12-12
EA201490867A1 (ru) 2014-12-30
US10634589B2 (en) 2020-04-28
KR20140079829A (ko) 2014-06-27
CN104136047B (zh) 2018-02-06
BR112014010027A2 (pt) 2017-04-25
HK1203423B (ru) 2018-08-17
EP2771038A1 (en) 2014-09-03
JP6539246B2 (ja) 2019-07-03

Similar Documents

Publication Publication Date Title
EA201992617A1 (ru) Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения
EA201390190A1 (ru) Ингибиторы вируса гепатита с
EA201892151A1 (ru) Способ синтеза 2-гидрокси-6-((2-(1-изопропил-1h-пиразол-5-ил)пиридин-3-ил)метокси)бензальдегида
EA201270656A1 (ru) Ингибиторы вируса гепатита с
EA201391152A1 (ru) Ингибиторы вируса гепатита с
EA201101082A1 (ru) Ингибиторы вируса гепатита с
EA201171208A1 (ru) Ингибиторы вируса гепатита с
EA201390856A1 (ru) Инактивация вирусов с применением улучшенного способа растворитель-детергент
DK3351630T3 (da) Farmaceutisk sammensætning omfattende anti caprin-1-antistoffer til behandling og/eller forebyggelse af cancer
MX344268B (es) Proceso para purificacion de proteinas.
EA201190224A1 (ru) Ингибиторы гепатита c, содержащие конденсированные кольца
EA201270616A1 (ru) Ингибиторы вируса гепатита с
EA201490893A1 (ru) Переработка биомассы
EA201591786A1 (ru) Монотерапия gla для применения в лечении рака
EA200870164A1 (ru) Лечение вирусного гепатита
EA201791850A1 (ru) Борсодержащие малые молекулы
EA201270622A1 (ru) Ингибиторы вируса гепатита с
EA201370017A1 (ru) Ингибиторы вируса гепатита с
EP2267119A4 (en) PROCESS FOR VIRUS ENRICHMENT
BR112013008813A2 (pt) instalação de tratamento de resíduos e método de tratar resíduos contendo lama dessecada
EA201490688A1 (ru) 2-тиопиримидиноны
EA201370071A1 (ru) Способы и композиции для лечения рака легких
EA201690718A1 (ru) Способ обработки целлюлозосодержащей биомассы
EA201001749A1 (ru) Способ лечения недифференцированного артрита
EA201370187A1 (ru) Клеточная культуральная среда для уфс воздействия и относящиеся к ней способы